SUMMARY The levels of testosterone in pooled plasma from men and from women were measured by radioimmunoassay. Testosterone was isolated from plasma either by ether extraction (direct procedure) or by chromatography of the ether extract (chromatographic procedure). Three different antisera (all raised against testosterone-3-oxime albumin) were employed. An additional variable was the use of two tracers, [3H] testosterone and P 25 1] histamine testosterone. The latter tracer was employed in both a freshly prepared form and two months after labelling. The old tracer was used both in a nonpurified and repurified form.
employed in both a freshly prepared form and two months after labelling. The old tracer was used both in a nonpurified and repurified form.
The results were compared with those given by one of the antisera using the assay with chromatography. The validity of this assay was verified earlier using a test of radiochemical purity. In the statistical evaluation of the data, it was found that the assays of both plasma pools gave the same results as the validated assay, even with two other antisera, but only when the chromatographic purification was used. The direct assays gave significantly increased values for testosterone in the male plasma pool with one antiserum, and in the female plasma pool with all three antisera.
It is concluded that those assays may be considered valid which give results statistically indistinguishable from those obtained by the valid assay. These were all chromatographic assays and, in the man, also two direct assays.
The comparison of [3H] testosterone and [ 125 1] histamine testosterone as tracers did not indicate any major differences in the validity of the assays. When the 125I-tracer was employed, a moderate (1·5-2 fold) increase of sensitivity was seen with all three antisera, and the antisera could be used in a 10--40 times higher dilution. Furthermore, it was possible to use [ 125 1] histamine testosterone and obtain practically the same results after two months, whether repurified or not.
According to a previously published definition,' an assay is considered valid if it exhibits the highest degree of accuracy, that is, if the results express the true contents in unknown samples.
The validity of a radioimmunoassay can be established by a comparison of the results with those obtained by an independent method, for example, mass fragrnentography.s Alternatively, the validity can be assessed using the radioimmunoassay technique itself by demonstrating radiochemical purity in the chromatographic peak of a compound subjected to radioimmunoassay. 1 Other radio-immunoassays, although they may differ in the antiserum, purification, or tracer employed, may also be considered valid by inference if they-within the limits of an accepted assay error-yield the same results as the validated assay.
Earlier studies indicated that the specificity of the antiserum available, the nature of the plasma samples investigated, and the degree of purification of plasma before radioimmunoassay, determine whether a high accuracy can be achieved or not.3-3 The assessment of accuracy, however, was based in these studies on the comparison of results from various assay procedures without having a validated method as a reference point.
It was the aim of the present investigation to ascertain which degree of purification is required for achieving validity in testosterone radioimmunoassays. This question was studied for three selected antisera and two plasma pools using as a reference method a procedure previously validated by means of a test of radiochemical purity." Furthermore, because of a renewed interest in employing iodinated tracers in steroid radioimmunoassays, a study of the possible influence of the tracer on assay validity was included in the present investigation.
[3H] Testosterone and [ 1251] histamine testosterone were compared as tracers. Using the latter compound, a possible effect of the decay 0[1 25 1 was also studied.
Material and methods

CLINICAL MATERIAL
The male plasma pool was collected from six men (aged 32--45 years), the female pool from eight women (aged 22-36 years) with normal menstruation. Individual blood samples (20 ml) were taken by venepuncture; they were collected in heparinised test tubes and centrifuged immediately. Both the individual plasma samples and the pools were stored at -20°C. The levels of dihydrotesterone (17[3-hydroxy-5oc-androstan-3-one) in the male and female plasma pools were 1·62 nmol/l and 0·70 nmol/l, respectively, as measured using the radioimmunoassay procedure described previously. 8 
REAGENTS
All steroids were purchased from Steraloids Inc (Wilton, New Hampshire, USA). They were recrystallised, and the purity was checked by thin-layer chromatography and melting-point determinations. All other reagents were of analytical grade. All solvents, except ether, were redistilled before use.
[3 H] TESTOSTERONE [1,2,6,7- The method of preparation of the tracer was essentially the same as described earlier. " [ 1251] Histamine was coupled to testosterone (O-carboxymethyl) oxime by the mixed anhydride method. After repeated washings of the reaction mixture at pH 1 the product was extracted with ethyl acetate. The tracer was purified by thin-layer chromatography on silica gel plates (Merck, Darmstadt, Germany) in a chloroform:methanol:acetic acid (90:10:1 v:v) mixture (R, = O·39). The tracer was eluted from the plates with methanol and stored in this solvent. The estimated specific radioactivity was 100 Ci/mmol. This tracer was used either within two weeks of Gomez, Frei, Vitins, and Cekan radioiodination or after two months. The two-monthold tracer was used either nonpurified or repurified using the same thin-layer chromatography as described above.
ANTISERA
Testosterone antiserum 741 no. 7 raised by Dr G E Abraham against testosterone (O-carboxymethyl) oxime-human serum albumin was purchased from the Professional Staff Association, Harbor General Hospital, Torrance, California, USA. Testosterone antisera 11-7 and 12-8 were produced in rabbits using testosterone (O-carboxymethyl) oxime-bovine serum albumin as immunogen. The immunisation and evaluation of these two antisera were performed at the Swiss Federal Institute for Reactor Research, Wtirenlingen. Antisera 741 no. 7, 11-7, and 12-8 are denoted X, Y, and Z, respectively, in this paper.
RADIOIMMUNOASSAY
The plasma was assayed according to the direct procedure in the following manner: Female pooled plasma (2 ml) was extracted with ether (20 ml), the aqueous phase was frozen in a mixture of ethanol with solid carbon dioxide, the organic phase was decanted, evaporated under nitrogen, and the residue was dissolved in assay buffer (1'0 ml) by heating for 10 minutes at 60°C. Out ofthis solution 0'1, 0,05, and 0·025 ml, respectively, was taken for the assay, each volume in triplicate. The volumes were all made up to 0·1 ml. Male pooled plasma was assayed in the same way, with the exception that 0·2 ml of plasma was taken and extracted with 2 ml of ether.
In the chromatographic procedure testosterone was purified on a celite: ethylene glycol (2: 1 wIv) column as described earlier.P Testosterone was obtained in the fraction (3 ml; isooctane :toluene 8:2) that was earlier-? used for the separation of 17-hydroxyprogesterone. This compound did not measurably cross-react with the antisera investigated. Plasma (1 ml for the female, 0·1 for the male plasma) was mixed with the 3H-tracer (approx. 2000 dpm in 0·1 ml assay buffer). After equilibration for 15 minutes at room temperature the plasma was extracted with ether (10 ml for female, 1 ml for male plasma). The organic phase was evaporated under nitrogen, dissolved in iso-octane (1 ml), and applied to a column. The testosterone fraction was evaporated under nitrogen and dissolved in assay buffer (0' 3 ml). This experiment was always performed with nine replicates. The assay buffer solutions were divided randomly into three groups of three replicates. In the first, second, and third groups, O·1,0' OS, and 0'025 ml of the solution, respectively, was taken for assay and the volume was made up to 0'1 mI. From all the nine replicates 0,1 ml was taken for recovery measurements.
The radioimmunoassay was performed according to the procedure described earlier" for a 3H-testosterone tracer. The assays using 126I-histamine testosterone as tracer were executed in the same way except that 4 x 10 4 dpm was used (instead of 1 x 10 4 dpm of 3H-testosterone), and that the radioactivity was measured in a 'Y-counter (Model 1185; Nuclear-Chicago [Searle & Co.], Des Plaines, Ill, USA). -0: iodinated tracer, used up to two weeks after preparation; 1-2: iodinated tracer, two months old, nonpurified; 1-2P: iodinated tracer, two months old, repurificd; H: tritiated tracer. tFor the origin ofindividua1 antisera, cf. Material and methods.
D~direct procedure; C~chromatographic procedure. §Means of measurements of three plasma dilutions which were assayed in triplicate; standard deviations in parentheses.
See Table I for explanation ofsymbolsot~ § "Lost due to a laboratory accident.
Antiserumt
The levels of testosterone shown in each row of Tables 1 and 2 were always measured in one single assay, to eliminate the between-assay variation in the comparison of the antisera and purification procedures. An analysis of variance of the data indicated that in the male plasma ( Table 1) the means of the columns (measurements obtained with the four tracers) were indistinguishable from that given by the valid procedure (antiserum X, chromatography; cf. Discussion and ref. 7) except for the mean obtained by the direct measurement using antiserum X which gave a significantly (p<O'OOI) higher result.
In the female plasma (Table 2) , on the other hand, only the chromatographic procedures using antisera Y and Z yielded results indistinguishable from the valid one (antiserum X, chromatography). The direct assays invariably yielded significantly higher results (p<O·OOI for X and Y, p<0·05 for Z).
When comparing the results obtained with the various tracers, it has to be borne in mind that the experimental design used could not exclude the influence on the between-assay variation; hence an unequivocal evaluation of the results cannot be tFor explanation, cf. Table I and Material and methods.
The dilution of antisera as present in the assay tubes. §The dose of the Iincarised standard curve corresponding to logit +2.
IIMeasun:d at SO %binding related to "zero" tubes.
-presented. Nevertheless, inspection of the data indicates that the differences between the tritiated and iodinated tracers were very small, if any, as far as the measurements of testosterone levels (Table 1 and 2) were concerned. The use of the 120I-tracer resulted in a moderate increase of assay sensitivity (1' 5-2 fold; cf. Table 3) with all three antisera. The measurements of crossreactions (Table 3) did not indicate any major difference between the 3H-and 12°I-tracers for any of the three antisera investigated. The small differences observed must be considered as falling within the margin of errors typical for the measurement of cross-reactions. There was a considerable difference in the final dilutions of the individual antisera with respect to the tracer used. The iodinated tracer could be used in a 10 times higher dilution with antisera X and Y, and in a 40 times higher dilution with antiserum Y (Table 3) .
Discussion
The present investigation is based on a comparison of various assay procedures with another one of established validity. The principle of the validity test and its application to the assays of progesterone and levonorgestrel were described earlier. I 11 12 This test is based on the assessment of radiochemical purity of the chromatographic peak used for the radioimmunoassay. The radiochemical purity is estimated by the measurements of specific activity (dpmjpg) in individual chromatographic fractions of the peak. In the case of the progesterone'! and levo-norgestrel'" radioimmunoassays, the constancy of specific activities constituted evidence of radiochemical purity. In the assay of testosterone, however, a constant specific activity could not be achieved due to a significant isotope effect. It was therefore necessary to replace the statistical test of the constancy of specific activities (testing the slope against zero) with a comparison of the slopes of specific activities over a chromatographic peak using the chromatography of authentic testosterone on the one hand, and the chromatography of plasma testosterone on the other. Using the present male and female pools in repeated tests, it was demonstrated? that the celite chromatography and antiserum X yielded a valid test in both pools, and, therefore, the results of this assay were used as reference values for the assessment of validity of the other procedures, using different antisera and/or omitting the chromatographic step.
The investigations performed in this way and presented in this paper demonstrated that the validity Gomez, Frei, Vitins, and Cekan of a steroid radioimmunoassay is to a great extent dependent on the biological material assayed. Thus the assay of the male pool was considerably more accurate than that of the female plasma pool; the chromatographic as well as direct procedures using antiserum Y and Z, respectively, yielded the same results as the validated assay, and only the direct assay using antiserum X resulted in overestimated results. On the other hand, a chromatographic purification was needed in the female pool for all three antisera if valid results were to be achieved. This phenomenon can be explained by an approximately 15 times lower content to testosterone in the female than in the male pool. A relatively high amount of other plasma constituents can thus more readily interfere in the assay of low concentrations of testosterone in the female pool.
The present data point to the hazard of translating the assumption of validity of a procedure from one biological material to another. This may be seen, for example, with the direct procedure using antiserum Y. In the male pool, the result was valid. In the female plasma pool, the result was grossly overestimated.
In contrast to the previous data concerning norethisterone radioimmunoassays.s the formal specificity of the three antisera, as established by cross-reactions with a few structurally related compounds, was well correlated with the real specificity, as established by assaying plasma samples. This indicates that the compounds tested for cross-reactions substantially contributed to the overestimations observed, especially in the female plasma pool when the direct procedure was employed. The role of dihydrotestosterone seems to be particularly important in this context. As demonstrated by both the present and earlier data,13 14 the levels of dihydrotestosterone in male plasma represent only some 10 % of testosterone levels, whereas this percentage is approximately 75 in the female plasma.
The use of the 120I-tracer did not bring about any marked improvement of specificity and accuracy in comparison with the 3H-tracer in the direct assays of the female plasma, as might have been expected. is Both the plasma data and cross-reaction studies indicated that there was no significant difference between the tracers.
In accordance with earlier data,IS the use of the 126I-tracer was associated with an increase of assay sensitivity with all three antisera. This increase, however, was rather moderate (1' 5-2 fold), which, on theoretical grounds.t? may be attributed to the relatively low specific activity (-100 Cijmmol) of the batch of the iodinated tracer used.
According to a number of earlier papers, the 125I-histamine tracer can be used for at least two months after preparation.v-" IB The present study confirms this conclusion on the basis of plasma assays. A repurification of the tracer two months after preparation did not have any noticeable effect on assay results.
A major difference between both tracers is that antisera can be used in considerably higher dilutions with the 125 1_ histamine tracer than with the 3H-tracer. This phenomenon, which is of great importance when rare antisera are used, has been described earlier. 20 The advantages and disadvantages of 1251-tracers in comparison with 3H-tracers have been critically assessed previously.1821 The results presented here are in accordance with the earlier assessment.
Nevertheless we can conclude from the present data that there is no major difference between the two tracers in terms of assay validity. Therefore, the decision about which tracer to use in a given testosterone radioimmunoassay must be based mainly on practical considerations.
In conclusion, comparison of the results given by various radioimmunoassay procedures with a valid one seems to be a method of choice whenever the validity of a variety of procedures has to be assessed.
